Press Releases and News Releases for Year 2012
Clarification of Prior Press Release on FDA Issuance of Orphan Status for PermaDerm®
Clarifies the designation of "Orphan Status" used in the earlier press release on June 12, 2012.
FDA Issues Orphan Status Approval for PermaDerm®
Regenicin, Inc. announces that the Food and Drug Administration (FDA) has granted Orphan Status approval for the PermaDerm® product, the only tissue-engineered skin prepared from autologous (patient’s own) skin cells consisting of both epidermal and dermal layers.